发明名称 |
INHIBITION OF INFLAMMATION USING ANTAGONISTS OF MUC1 |
摘要 |
The invention provides for peptides from the MUC1 cytoplasmic domain and methods of use therefor. These peptides can inhibit MUC1 oligomerization, inhibit the interaction of MUC1 with NF-κB or a STAT, and block inflammatory response mediated by NF-κB or STAT signaling. |
申请公布号 |
US2014187494(A1) |
申请公布日期 |
2014.07.03 |
申请号 |
US201314138521 |
申请日期 |
2013.12.23 |
申请人 |
GENUS ONCOLOGY, LLC ;DANA-FARBER CANCER INSTITUTE, INC. |
发明人 |
KUFE Donald W.;KHARBANDA Surender |
分类号 |
C07K14/705;A61K45/06;A61K38/17 |
主分类号 |
C07K14/705 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of inhibiting inflammatory signaling in a subject suffering from acute pancreatitis comprising contacting said cell with a MUC1 peptide of at least 6 consecutive MUC1 residues and no more than 20 consecutive MUC1 residues and comprising the sequence CQCRRK. |
地址 |
VERNON HILLS IL US |